Click the desired story title below to read more or subscribe to our email newsletter.

NAEJA Receives $10 Million Boost For Drug Discovery

Resverlogix Corp. Announces Agreement with Leading Pharmaceutical Research Organization

Entomed And NAEJA Pharmaceutical Inc Enter Two-Way Agreement To Identify New Leads In Infectious Diseases And Cancer

NAEJA Presents at BioPartnering North America

Chirologix And NAEJA Enter Into Two Agreements On Antibiotics

PanTherix to Develop NAEJA Pharmaceutical Inc's Syn2416

Microcide Pharmaceuticals Collaborates With NAEJA Pharmaceutical On Antifungals

Research with Japanese Pharmaceutical Giant Results in New Biotech Company

News Inquiry